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The effect of short- and long-term feeding with L-carnitine, L-acetyl carnitine and L-propionyl carnitine 
on the production of eicosanoids from in vitro stimulated carrageenan-induced rat peritoneal 
macrophages was investigated. Both young (4 weeks) and old (18 months) rats were used. A lower 
number of cells was isolated from the peritonea of treated than control young rats after 4 d feeding, but 
after 60 d no differences were observed. A similar reduction in cell number was found when old animals 
were given L-acetyl carnitine or L-propionyl carnitine (acutely) or L-acetyl carnitine or L-carnitine 
(chronically). Plasma carnitine levels were higher in young rats given carnitine both chronically and 
acutely. Carnitine derivatives were without effect. In contrast, levels of total carnitine in the plasma of 
old rats given L-carnitine and Lacetyl carnitine for 4 d and 60 d were higher than in controls. There was 
no correlation between total plasma carnitine level and effects on prostaglandin, thromboxane and 
leukotriene B4 (LTBJ production. In young rats the most important changes were observed in relation 
to the production of prostacych (PGI3, measured as 6 keto-prostaglandin Flm. Prostacyclin production 
was higher in the groups given carnitine or its derivatives. The net result of the changes in PGI, was that 
the 6 keto-prostaglandin F,,:thromboxane B, and the 6 keto-prostaglandin F,,:LTB, ratios tended to 
be higher in cells from young animals following short-term feeding with ~carnitine. When young rats 
were given carnitine compounds for 60 d PGI, production was lower in cells from L-acetyl carnitine- and 
L-propionyl carnitine-fed animals. The net result of the changes in PGI, was that the 6 keto- 
prostaglandin F,,:thromboxane B, and the 6 keto-prostaglandin F,,:LTB, ratios were lower in cells 
from animals fed with carnitine compounds. In old rats the PGI, production was lower after short-term 
feeding with carnitine compounds and was higher after long-term feeding. LTB, production was lower 
after L-carnitine and L-acetyl carnitine treatment for 4 d and also lower after 60 d treatment with 
L-acetyl carnitine. The net results of the changes in PCL, were that the 6 keto-prostaglandin 
F,,:tbromboxane B, and the 6 keto-prostaglandin F,,:LTB4 ratios were lower after short-term feeding 
of all three compounds and higher after the long-term treatment with bacetyl carnitine and L-propionyl 
carnitine in old rats. By long-term treatment with low-dose aspirin of patients with heart failure and 
claudication, the 6 keto-prostaglandin F,,:thromboxane B, ratio is positively increased, which is a 
beneficial cardioprotective effect. The mechanism of action of carnitine in heart failure and claudication 
could also be achieved by an increase of this ratio. Our results suggest that elderly patients could be 
treated chronically by carnitine to obtain this beneficial effect. 
~Carnitine :Peritoneal macrophages : Eicosanoids 
Before long-chain fatty acids are oxidized in mitochondria they are activated by acyl 
coenzyme A (acyl CoA) synthetase (EC 6.2.1.3) and carried across the mitochondria1 
* Present address: Department of Pharmacology. Medical Biological Laboratory, TNO, PO Box 45,2280 AA, 
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inner membrane by L-carnitine (P-hydroxy-(7-N-trimethy1amino)-butyrate). Carnitine 
deficiency, defined as a decrease in intracellular carnitine, leads to the accumulation of acyl 
CoA esters within the cell and an inhibition of acyl transport through the mitochondria1 
inner membrane. Inhibition of the mitochondrial Boxidation results in fatty acid 
infiltration and, eventually, heart or liver failure (Barth et al. 1983; Scholte et al. 1989, 
1990; Wanner et al. 1989). Carnitine deficiency can be due to a genetic deficiency, or may 
occur as a side-effect of dialysis treatment. For example, serum carnitine and leucine levels 
were significantly decreased in patients on continuous ambulatory peritoneal dialysis 
(CAPD) for more than 4 months. This observation suggests that malabsorption plays a role 
in the reduction of serum carnitine levels in patients receiving CAPD (Murakami et al. 
1990). The clinical conditions of infants and children with a variety of diagnoses associated 
with low circulating carnitine concentrations improved after carnitine supplementation, 
and carnitine has been reported to have several beneficial effects on ischaemic heart diseases 
and arrhythmias in man, where it augments the ischaemic heart tolerance to stress 
(Schinetti & Mmzini, 1986). 
Carnitine administration may also have beneficial effects in patients with disorders of 
NH, metabolism (Ohtsuka & Griffith, 1991 ; Rebouche, 1992). Interestingly, adults 
suffering from chronic diseases associated with ageing, such as heart disease or 
cardiomyopathy due to carnitine loss, are improved by treatment with L-carnitine, L-acetyl 
carnitine or L-propionyl carnitine (Winter et al. 1987; Scholte et al. 1989, 1990; Wanner et 
al. 1989; Rebouche, 1992). 
Besides its stimulation of fatty acid oxidation, L-carnitine has also been shown to 
enhance the formation of arachidonic acid from linoleic acid by isolated hepatocytes. It was 
suggested that this was due to the removal of the inhibitory effect of long-chain acyl CoA 
on acetyl CoA carboxylase (EC 6.4.1 .2), a regulating enzyme in fatty acid synthesis, by 
long-chain acyl carnitine (McGarry et al. 1975; Christophersen & Norseth, 1981; 
Rebouche, 1986; Stryer, 1988; Conte et al. 1992). This increased arachidonic acid synthesis 
could be important, as eicosanoids, metabolites of arachidonic acid, are important local 
modulators of inflammation. For example, the cyclooxygenase product prostaglandin 
E, (PGE,) is recognized as an important inhibitor of both cell migration and mediator 
formation, whereas leukotriene B, (LTB,), a lipoxygenase (EC 1.13.11.12) product, is a 
potent chemotactic agent which promotes the formation of mediators at inflammatory sites 
(Lehmann et al. 1988; Renz et al. 1988; Schepers et al. 1988; Yamaoka er al. 1988). 
Furthermore, the ratio between the vasoconstrictive prostanoid thromboxane A, (TxA,), 
synthesized by platelets, and the vasodilative prostacyclin (prostaglandin I, ; PGI,), 
synthesized by endothelial cells, is of importance in controlling platelet aggregation and 
adherence to blood vessels (Campbell, 1990). CoA also plays a role in the formation and 
breakdown of products from both the cyclooxygenase and lipoxygenase pathways of 
arachidonic acid metabolism (Conte et al. 1992). Recently the oxidation of PGE, in rat liver 
peroxisomes and mitochondria was shown to require the activation to PGE, CoA by 
microsomal PGE, CoA synthetase (Schepers et al. 1988). Furthermore, LTB, is degraded 
through w- and b-oxidation in neutrophils and liver cells. The formation of LTB, CoA 
esters which occurs in rat-liver microsomes may be essential for LTB, ,&oxidation 
(Yamaoka et al. 1988). While LTB, is a potent chemotactic agent and promotes the 
formation of mediators at inflammatory sites, its degradation products are less potent than 
the parent compound. Hence the formation of LTB, CoA esters and their subsequent p- 
oxidation might be of importance in limiting LTB, activity at the sites of inflammation. 
Thus, carnitine could stimulate both the synthesis and breakdown of eicosanoids by the 
same mechanism, i.e. reducing the concentration of long-chain acyl CoA within the cell. 
Recently we showed that feeding young rats (3-4 months) with L-carnitine or various 
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derivatives resulted in a preferential higher production of PGI, by peritoneal macrophages 
(Elliott et al. 1990). Our results could provide the basis for a possible explanation for the 
beneficial effects of carnitine and its derivatives in cardiovascular diseases. Such 
investigations into the mechanisms of L-carnitine and its derivatives may lead to the 
identification of new roles for these compounds. 
In the present study we extended our investigations by examining the effect of 
L-carnitine, L-acetyl carnitine (formed during P-oxidation of even-chain fatty acids) and 
L-propionyl carnitine (formed during &oxidation of uneven-chain fatty acids) on 
eicosanoid production by carrageenan-induced peritoneal cells of young and old rats after 
4 or 60 d exposure. Earlier results obtained using young rats given carnitine compounds for 
4 d are shown for ease of comparison (Elliott et al. 1990). 
MATERIALS A N D  METHODS 
Materials 
L-Carnitine, L-acetyl carnitine, and L-propionyl carnitine were gifts from Sigma-Tau 
Pharmaceutical Co. (Rome, Italy). Carrageenan was purchased from Marine Colloids Inc 
(Springfield, NJ, USA). Lymphoprep was from Nyegaard Diagnostica (Oslo, Norway) and 
Dulbecco’s modified Eagle’s medium was obtained from Life Technologies (Breda, The 
Netherlands). A23 187 was from Sigma (Axel, The Netherlands). ‘H-labelled eicosanoids 
were from Amersham (‘s-Hertogenbosch, The Netherlands) and antibodies from Advanced 
Magnetics Inc. (Cambridge, MA, USA). Other chemicals were purchased from Merck 
(Amsterdam, The Netherlands) and Sigma. 
Animals 
Male Wistar rats were used in all experiments. The animals were housed in groups of three 
in polyethylene cages with food and water ad lib. Artificial light was supplied in a 12 h 
light-dark cycle. 
Treatment 
Two series of experiments were carried out. 
Short-term treatment. Young rats ( 3 4  months, nine rats per group) and old rats (16-18 
months, five rats per group) were given by intubation on days 1 4 ,  300 mg L-carnitine or 
carnitine equivalents (L-acetyl carnitine and L-propionyl carnitine)/kg dissolved in 1 ml 
distilled water. Control animals were given distilled water. All animals were injected 
intraperitoneally with 2 ml of a carrageenan solution (1 mg/ml) on day 1 (Elliott et al. 
1990). 
Long-term treatment. Young rats (3-4 months, nine rats per group) and old rats (16-18 
months, five rats per group) were given in their drinking water on days 1-60, 50mg L- 
carnitine or carnitine equivalents (L-acetyl carnitine and L-propionyl carnitine)/kg. Control 
animals were given water. All animals were injected intraperitoneally with 2ml of a 
carrageenan solution (1 mg/ml) on day 56 (4 d before the end of the experiment). 
Isolation and incubation of peritoneal cells 
On day 4 or 60, 1 h after the last administration of L-carnitine or its derivatives, cells were 
isolated from pooled Gey’s balanced-salt solution washes of the peritonea of the rats by 
density-gradient centrifugation over Lymphoprep and suspended in Dulbecco’s modified 
Eagle’s medium (2 x loe nucleated cells/ml). The harvested peritoneal cell population 
consisted of > 85 % macrophages and > 10 % polymorphonuclear leucocytes. A 1 ml 
portion of cell suspension was incubated at 37” for either 2 h without ionophore (basal 
788 I. M. GARRELDS AND OTHERS 
Table 1. Efect of short- and long-term feeding of L-carnitine or its congeners on the 
absolute cell number ( x lo6) isolated from peritonea of young and old rats? 
(Values are means and standard deviations for nine (young) and five (old) rats) 
L-Acetyl L-Propionyl 
Control L-Carnitine carnitine carnitine 
Treatment Mean SD Mean SD Mean SD Mean SD 
~ ~ 
Young rats Short-term 13.33 3.73 6.34* 1.95 4.91* 0.38 6.48* 1.29 
Long-term 13.92 3.22 12.94 2.32 14.52 5.31 13.01 3.11 
Old rats Short-term 13.80 1.55 12.44 1.86 6.28* 0.51 7%9* 1.37 
Long-term 15.30 2.59 8.41* 2.07 8-39* 038 14.29 2.40 
Mean values were significantly different from control values: * P < 0.05 (Students I test). 
t For details of procedures, see pp. 787-788. 
production) or 30 min with lo-‘ ~ - A 2 3  187 (ionophore-stimulated production). The cell 
suspensions were then centrifuged and the supernatant fractions analysed for production 
of LTB,, PGE,, TxB,, and 6 keto-prostaglandin F,, (6 keto-PGF,J by radioimmunoassays 
(Zijlstra & Vincent, 1984; Elliott et al. 1990). The net eicosanoid production was calculated 
by subtraction of the basal production from the ionophore-stimulated production. Blood 
samples were taken for measurement of total plasma carnitine levels (Pande & 
Caramancion, 1981; Rossle et al. 1985). 
Statistical evaluation 
In the experiments the values are given as means and standard deviations for either nine 
or five rats per group. Statistical significance was calculated using the Student’s t test. 
RESULTS 
Results obtained using young rats fed with carnitine compounds for 4 d  have been 
previously published (Elliott et al. 1990) and are given here solely for the purposes of 
comparison. 
Cell number 
Young rafs, short-term. All three compounds significantly reduced the number of nucleated 
cells isolated from peritonea 4 d after an intraperitoneal injection of carrageenan. 
Young rats, long-term. No differences were found between the groups with respect to the 
number of nucleated peritoneal cells isolated after 60 d. 
Old rats, short-term. L-Acetyl carnitine and L-propionyl carnitine significantly reduced 
the number of nucleated cells isolated from the peritonea after 4 d treatment. 
Old rats, long-term. L-Carnitine and L-acetyl carnitine significantly reduced the number 
of nucleated cells isolated from the peritonea 60 d after treatment (Table 1). 
Plasma levels of carnitine 
Of the three compounds used, only in the L-carnitine group was the total L-carnitine 
concentration in plasma higher in all experiments in comparison with the controls (Table 2). 
In the L-acetyl carnitine group the total L-carnitine concentration in the plasma of old 
rats (chronic and acute) was higher than in controls. 
EFFECT OF L-CARNITINE O N  EICOSANOIDS 789 
Table 2. Efect of short- and long-term feeding of L-carnitine or its congeners on the 
plasma levels (umolll) of carnitine in young and old rats? 
(Values are means and standard deviations for nine (young) and five (old) rats) 
L-Aetyl L-Propionyl 
Control L-Carnitine carnitine carnitine 
Treatment Mean SD Mean SD Mean SD Mean SD 
Young rats Short-term 66.3 4.5 102*4* 18.7 75.3 11.2 76.1 19.9 
Long-term 767 9 1  125.3* 14.2 82.6 15.3 86.0 14.6 
Old rats Short-term 81.6 17.5 1384* 20.0 114.2* 11.4 109.3 23.7 
Long-term 69.2 152 95.9* 9.9 98.4* 18.0 885 24.8 
Mean values were significantly different from control values: * P c 005 (Students r test). 
t For details of procedures, see pp. 787-788. 
10 
Control L-Carnitine L-Acetyl L-Propionyl Control L-Carnitine L-Acetyl L-Propionyl 
carnitine carnitine carnitine carnitine 
Fig. 1. Effect of short- (4 d; panels (a) and (c)) and long-term (60 d; panels (b) and (4) feeding of L-carnitine, L- 
acetyl carnitine and ~-propionyl carnitine on the production of prostaglandin E, (m), thromboxane B, (m), and 
6 keto-prostaglandin F,, (m) from carrageenan-induced peritoneal cells of young and old rats. Values are means 
with standard deviations indicated by vertical bars. Mean values were significantly different from control values: 
* P < 0.05 (Student's t test). For details of procedures, see pp. 787-788. 
Production of eicosanoids from carrageenan-induced peritoneal cells 
Young rats. In the short-term experiments the production of 6 keto-PGF,, and TxB, 
tended to increase with L-acetyl carnitine and L-propionyl carnitine (Fig. 1). Production 
of 6 keto-PGF,, was significantly higher and that of TxB, tended to be higher after feeding 
with L-carnitine. LTB, production was significantly higher in all three treatment groups 
(Table 3). However, no effects on PGE, formation were detected. The 6 keto-PGF,,:TxB, 
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Table 3. Eflect of short- and long-term feeding of L-carnitine or its congeners on the net 
production of leukotriene B, (ng/2 x lo6 macrophages) from peritoneal cells in young and 
old rats? 
(Values are means and standard deviations for nine (young) and five (old) rats) 
~ 
L- Acet yl L-Propionyl 
Control L-Carnitine carnitine carnitine 
Treatment Mean SD Mean SD Mean SD Mean SD 
Young rats Short-term 077 0.36 1.54* 0.87 1.72* 1.19 1.19* 0.72 
Long-term 037 0.19 0.63 070 0.31 0.40 0.25* 0.23 
Old rats Short-term 1.42 0.21 0.93* 0.30 1.17. 0.35 1.03 060 
Long-term 0.33 0.13 0.38 0.17 0.05* 0.03 0.26 0.14 
Mean values were significantly different from control values: * P < 0.05 (Students t test). 
t For details of procedures, see pp. 787-788. 
Table 4. Effect of short- and long-term feeding of L-carnitine or its congeners on the 6 
keto-prostaglandin 4,: thromboxane B, ratio of peritoneal cells from young and old rats? 
(Values are means and standard deviations for nine (young) and five (old) rats) 
L-Acetyl L-Propionyl 
Control L-Carnitine carnitine carnitine 
Treatment Mean SD Mean SD Mean SD Mean SD 
Young rats Short-term 1.72 1.55 3.80 4.05 1.26 1.38 0.87 0.70 
Long-term 071 0.23 097* 0.11 0.29* 0.06 0.28. 0.08 
Old rats Short-term 1.65 043 0-90* 0.16 022* 0.08 0.46* 0.17 
Long-term 015 006 048* 025 076' 0.27 0.52. 0.19 
Mean values were significantly different from control values: *P < 0.05 (Students f test). 
t For details of procedures, see pp. 787-788. 
and the 6 keto-PGF,,: LTB, ratios, calculated from the net values, tended to be higher with 
L-carnitine treatment (Tables 4 and 5) .  This was due to the fact that the stimulation of 6 
keto-PGF,, production was greater than that of the other eicosanoids measured (Elliott et 
al. 1990). 
In the long-term experiments the 6 keto-PGF,, production was significantly lower in the 
L-acetyl carnitine and L-propionyl carnitine groups, while it was not in the L-carnitine 
group. No changes in PGE, production were detected (Fig. 1). LTB, production was 
significantly lower after feeding L-propionyl carnitine (Table 3). This resulted in significantly 
lower 6 keto-PGF,,: TxB, and 6 keto-PGF,,: LTB, ratios after treatment with L-acetyl 
carnitine and L-propionyl carnitine, but a significantly higher 6 keto-PGF,, : TxB, ratio in 
the L-carnitine group compared with controls (Tables 4 and 5) .  
Old rats. In the short-term experiments the production of 6 keto-PGF,, was significantly 
lower in all carnitine groups and the TxB, production was significantly lower in the 
L-propionyl carnitine group. No changes in PGE, production were detected (Fig. 1). LTB, 
production was significantly lower after L-carnitine and L-acetyl carnitine treatments. The 
6 keto-PGF,,: TxB, and 6 keto-PGF,, : LTB, ratios were significantly lower in all three 
treatment groups than in the control group. 
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Table 5 .  EfSect of short- and long-term feeding of L-carnitine or its congeners on the 6 
keto-prostaglandin F,, : leukotriene B, ratio of peritoneal cells from young and old rats? 
(Values are means and standard deviations for nine (young) and five (old) rats) 
L-ACetyl L-Propionyl 
Control L-Camitine carnitine carnitine 
Treatment Mean SD Mean SD Mean SD Mean SD 
Young rats Short-term 4.88 2.90 12.99 8.35 8.74 8.29 7.13 4.47 
Long-term 18.32 7.25 11.83 9.20 655* 6.15 5.48* 3.67 
Old rats Short-term 9.16 1.86 553* 1.56 1.10* 0.40 0.61* 0.32 
Long-term 5.21 1.99 18-32 9.53 87.86* 3822 2056* 9.69, 
Mean values were significantly different from control values: * P < 0.05 (Students t test). 
t For details of procedures, see pp. 787-788. 
In the long-term experiments no significant effects on PGE, and TxB, production were 
detected. Only in the L-acetyl carnitine and the L-propionyl carnitine groups was a 
significantly lower production of 6 keto-PGF,, found (Fig. 1). LTB, production was 
significantly lower in the L-acetyl carnitine group after chronic exposure (Table 3). The 
6 keto-PGF,,:TxB, ratio was significantly higher in all three treatment groups and the 
6 keto-PGF,,: LTB, ratio was significantly higher in the chronic experiments after 
treatment with L-acetyl carnitine and L-propionyl carnitine (Tables 4 and 5) .  
DISCUSSION 
Only exposure to L-carnitine resulted in an elevation of total plasma L-carnitine in young 
rats (acute and chronic exposure). Both L-carnitine and acetyl carnitine treatment elevated 
total plasma L-carnitine in old rats. However, in view of the lack of a correlation between 
plasma Lcarnitine and other variables measured, the significance of these increases is not 
clear. One effect of feeding L-carnitine or its congeners to young rats for 4 d was the much 
lower number of carrageenan-elicited macrophages isolated from the peritonea of the 
treated animals. In contrast there was no effect when young rats were treated chronically. 
The effect of carnitine compounds on the number of elicited macrophages isolated from old 
rats was variable. Only in the L-acetyl carnitine group was a lower number of elicited 
macrophages found after both chronic and acute exposure. These results indicate that some 
L-carnitine compounds can modify the macrophage response to chemotactic signals 
generated when carrageenan is injected intraperitoneally. The exact effect depends on the 
age of the animal and time of exposure. A reduction of 50 YO in the number of macrophages 
at an inflammatory site could well be beneficial, for example in chronic immuno- 
inflammatory diseases. 
We previously demonstrated that PGI, production by rat and rabbit aortas increased 
with age (Adolfs & Elliott, 1982; Elliott & Adolfs, 1984; Vincent & Zijlstra, 1986). In the 
present study we also show that eicosanoid production by macrophages is increased with 
age. It now appears that an increase in the turnover of arachidonic acid could be a 
characteristic of ageing. From the short-term feeding experiments with older rats we 
conclude, in general, that L-carnitine and its derivatives inhibited PGI, production. In 
contrast, the production of PGI, after long-term feeding was stimulated. The net results of 
the changes in PGI, were that the 6 keto-prostaglandin F,,:thromboxane B, and the 
6 keto-prostaglandin F l a :  LTB, ratios were lower after short-term feeding of all three 
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compounds and higher in the long-term treatment with L-acetyl carnitine and L-propionyl 
carnitine in comparison with controls. The production of PGI, and TxB, from macrophages 
isolated from young test animals was higher than that from control rats after short-term 
feeding with L-carnitine and its derivatives. The results of these changes were that the 
6 keto-PGF,,: TxB, ratio and 6 keto-PGF,,:TxB, ratio were higher after short-term L- 
carnitine treatment. After long-term treatment with L-acetyl carnitine and L-propionyl 
carnitine a lower production of PGI, was observed. The net results were that the 6 keto- 
prostaglandin F,,: thromboxane B, and 6 keto-prostaglandin F1,: LTB, ratios were lower 
after feeding with L-acetyl carnitine and L-propionyl carnitine. 
In man the 6 keto-PGF,,:TxB, ratio is positively increased by long-term low-dose 
aspirin treatment, despite the fact that aspirin inhibits prostaglandin formation. This is 
because although aspirin inhibits the synthesis of platelet thromboxane A,, a vaso- 
constrictor and platelet activator, and of vascular endothelium prostacyclin synthesis, a 
vasodilator and platelet inhibitor (Haslam & McClenaghan, 1981; Weksler et al. 1983; 
Kallmann et al. 1987), the effect of aspirin on endothelium cyclooxygenase is much less 
than the effect on the platelets. The mechanism of action of carnitine in heart failure and 
claudication could be achieved by an increase in the 6 keto-PGF,,:TxB, ratio. Our results 
suggest that elderly patients could be treated chronically with carnitine to obtain this 
beneficial effect. Further clinical trials, in which both plasma eicosanoid levels and 
prostacyclin production are monitored, should be performed to test this hypothesis. 
These studies were supported by Sigma-Tau Pharmaceutical Co., Rome, Italy. 
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